BREWIN DOLPHIN LTD - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 213 filers reported holding IMMUNOMEDICS INC in Q4 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.6%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$170,060
+79.7%
2,000
-25.1%
0.01%
+57.1%
Q2 2020$94,625
+162.9%
2,6700.0%0.01%
+75.0%
Q1 2020$35,992
-49.1%
2,670
-20.1%
0.00%
-33.3%
Q4 2019$70,674
-41.9%
3,340
-63.6%
0.01%
-50.0%
Q3 2019$121,594
-4.4%
9,1700.0%0.01%
-7.7%
Q2 2019$127,188
-27.8%
9,1700.0%0.01%
-31.6%
Q1 2019$176,156
-7.3%
9,170
-31.2%
0.02%
-24.0%
Q4 2018$190,076
+45.4%
13,320
+112.3%
0.02%
+66.7%
Q3 2018$130,687
+3795.3%
6,274
+2514.2%
0.02%
Q3 2017$3,3552400.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,711,067$2,943,0001.70%
J.P. Turner & Co Capital Mnagement, LLC 248,625$428,0000.44%
Orbimed Advisors 3,323,000$5,716,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 2,004,078$3,447,0000.02%
WOLVERINE ASSET MANAGEMENT LLC 5,870$1,018,0000.02%
SIGNET FINANCIAL MANAGEMENT, LLC 44,675$77,0000.02%
SVB WEALTH LLC 195,000$335,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 288,900$497,0000.01%
J.P. Turner & Co Capital Mnagement, LLC 153,900$8,0000.01%
BALYASNY ASSET MANAGEMENT L.P. 640,400$1,101,0000.01%
View complete list of IMMUNOMEDICS INC shareholders